Evidence against involvement of P53 polymorphism in breast cancer predisposition

被引:63
|
作者
Suspitsin, EN [1 ]
Buslov, KG [1 ]
Grigoriev, MY [1 ]
Ishutkina, JG [1 ]
Ulibina, JM [1 ]
Gorodinskaya, VM [1 ]
Pozharisski, KM [1 ]
Berstein, LM [1 ]
Hanson, KP [1 ]
Togo, AV [1 ]
Imyanitov, EN [1 ]
机构
[1] NN Petrov Oncol Res Inst, Grp Mol Diagnost, St Petersburg 197758, Russia
关键词
D O I
10.1002/ijc.10834
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:431 / 433
页数:3
相关论文
共 50 条
  • [31] p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients
    Bourdon, Jean-Christophe
    Khoury, Marie P.
    Diot, Alexandra
    Baker, Lee
    Fernandes, Kenneth
    Aoubala, Mustapha
    Quinlan, Philip
    Purdie, Colin A.
    Jordan, Lee B.
    Prats, Anne-Catherine
    Lane, David P.
    Thompson, Alastair M.
    BREAST CANCER RESEARCH, 2011, 13 (01):
  • [32] The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer
    Lee, JM
    Shun, CT
    Wu, MT
    Chen, YY
    Yang, SY
    Hung, HI
    Chen, JS
    Hsu, HH
    Huang, PM
    Kuo, SW
    Lee, YC
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2006, 594 (1-2) : 181 - 188
  • [33] p53 codon 72 polymorphism and breast cancer risk: A meta-analysis
    Hou, Jing
    Jiang, Yuan
    Tang, Wenru
    Jia, Shuting
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (05) : 1397 - 1402
  • [34] A novel polymorphism in intron 6 of the human p53 gene: A possible association with colorectal cancer predisposition and susceptibility
    Peller, S
    Ziv, Y
    Koplivoa, Y
    Slutzki, S
    Halevy, A
    Rotter, V
    XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 535 - 537
  • [35] p53 expression and resistance against paclitaxel in patients with metastatic breast cancer
    M. Schmidt
    A. Bachhuber
    A. Victor
    E. Steiner
    M. Mahlke
    H. A. Lehr
    H. Pilch
    W. Weikel
    P. G. Knapstein
    Journal of Cancer Research and Clinical Oncology, 2003, 129 : 295 - 302
  • [36] p53 expression and resistance against paclitaxel in patients with metastatic breast cancer
    Schmidt, M
    Bachhuber, A
    Victor, A
    Steiner, E
    Mahlke, M
    Lehr, HA
    Pilch, H
    Weikel, W
    Knapstein, PG
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2003, 129 (05) : 295 - 302
  • [37] Involvement of p53 in gemcitabine mediated cytotoxicity and radiosensitivity in breast cancer cell lines
    Salem, Sameer D.
    Abou-Tarboush, Faisal M.
    Saeed, Nadeem M.
    Al-Qadasi, Waheeb D.
    Farah, M. Abul
    Al-Buhairi, Muneera
    Al-Harbi, Najla
    Alhazza, Ibrahim
    Alsbeih, Ghazi
    GENE, 2012, 498 (02) : 300 - 307
  • [38] Association of p53 arginine polymorphism with skin cancer
    de Oliveira, WRP
    Rady, PL
    Grady, J
    Hughes, TK
    Neto, CF
    Rivitti, EA
    Tyring, SK
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2004, 43 (07) : 489 - 493
  • [39] p53 genetic polymorphism of gastric cancer in Korea
    Chul, CW
    Moon, LK
    Mo, YJ
    Sik, CI
    GASTROENTEROLOGY, 2005, 128 (04) : A402 - A402
  • [40] P53 POLYMORPHISM IN OVARIAN AND BLADDER-CANCER
    LANCASTER, JM
    BROWNLEE, HA
    WISEMAN, RW
    TAYLOR, J
    LANCET, 1995, 346 (8968): : 182 - 182